Kazia Therapeutics Ltd
Pharmaceutical company · Sydney Nsw, New South Wales, Australia · Nasdaq: KZIA
Kazia Therapeutics Ltd is a pharmaceutical company headquartered in Sydney Nsw, New South Wales, Australia. Its shares trade on Nasdaq under the ticker KZIA. It has reported private securities offerings to the US SEC, most recently $55 million sold in a notice filed in 2025.
Kazia Therapeutics at a glance
What does Kazia Therapeutics do?
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $55.3 million sold (2025).
Frequently asked questions about Kazia Therapeutics
Where is Kazia Therapeutics headquartered?
Kazia Therapeutics Ltd is headquartered in Sydney Nsw, New South Wales, Australia.
What does Kazia Therapeutics do?
Kazia Therapeutics Ltd is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Kazia Therapeutics a public company?
Yes. Kazia Therapeutics Ltd trades on Nasdaq under the ticker KZIA.
Similar companies
- IMMUTEP LtdSydney, New South Wales, Australia
- Propanc Biopharma, Inc.Camberwell, Victoria, Australia
- Radiopharm Theranostics LtdCarlton, Victoria, Australia
- Alterity Therapeutics LtdMelbourne, Victoria, Australia
- Immuron LtdCarlton, Victoria, Australia
- Cyclomedica Australia PTY LtdKingsgrove, New South Wales, Australia
- Botanix Pharmaceuticals Ltd.North Perth, Western Australia, Australia
- Telix Pharmaceuticals LtdNorth Melbourne, Victoria, Australia
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-24. Data licences